fda bpc-157 warning letter or statement The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Banned: Key Facts
Description
Alternatively Activated Macrophages

No claims are made regarding safety, efficacy, or suitability for any specific research application or experimental outcome

BPC-157 can upregulate growth factors, accelerating healing and recovery
Hermann P, Gera I, Borbely J, Fejerdy P, Madlena M
